Literature DB >> 30170730

Long noncoding RNA LINC00339 aggravates doxorubicin-induced cardiomyocyte apoptosis by targeting MiR-484.

Jing Li1, Li Li2, Xun Li3, Saizhu Wu4.   

Abstract

Abnormally expressed long noncoding RNAs (lncRNAs) has been recognized as one of the key source in cardiac diseases. However, the role of lncRNA in doxorubicin (DOX)-induced cardiotoxicity remains largely unknown. In previous studies, we have screened some aberrantly expressed lncRNAs from an animal model for DOX-induced cardiotoxicity, and LINC00339 is one of the highly expressed lncRNA. In this study, we validated and further explored its regulatory mechanisms using in vitro model systems. Primary cultured myocardial cell (PC) and H9C2 cell line were treated with different concentrations of DOX and the expression of LINC00339 were markedly up-regulated. However, knockdown of endogenous LINC00339 by its siRNA improved cells proliferation activity and reduced cardiomyocyte apoptosis. Further experiments showed the opposite trend of expression between LINC00339 and miR-484. Bioinformatics analysis and luciferase reporter assay indicated that LINC00339 directly binds to miR-484. Moreover, miR-484 inhibitor abrogated the collagen synthesis inhibition induced by LINC00339. These findings reveal a novel function of the LINC00339/miR-484 axis in DOX-induced cardiotoxicity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Dilated cardiomyopathy; Doxorubicin; LINC00339; MiR-484

Mesh:

Substances:

Year:  2018        PMID: 30170730     DOI: 10.1016/j.bbrc.2018.08.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Long Noncoding RNAs Involved in Cardiomyocyte Apoptosis Triggered by Different Stressors.

Authors:  Jinghui Sun; Ru Wang; Tiantian Chao; Chenglong Wang
Journal:  J Cardiovasc Transl Res       Date:  2021-12-02       Impact factor: 3.216

Review 2.  Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity.

Authors:  Himani Kumari; Wan-Hong Huang; Michael W Y Chan
Journal:  Front Cardiovasc Med       Date:  2020-05-07

3.  Long non-coding RNA SNHG1 protects human AC16 cardiomyocytes from doxorubicin toxicity by regulating miR-195/Bcl-2 axis.

Authors:  Sisi Chen; Jichun Wang; Yanli Zhou
Journal:  Biosci Rep       Date:  2019-07-25       Impact factor: 3.840

4.  MiR-484 Protects Rat Myocardial Cells from Ischemia-Reperfusion Injury by Inhibiting Caspase-3 and Caspase-9 during Apoptosis.

Authors:  Huizi Liu; Sai Li; Wei Jiang; Yinjun Li
Journal:  Korean Circ J       Date:  2019-11-19       Impact factor: 3.243

5.  Potential Association of Circulating MicroRNA-181c and MicroRNA-484 Levels with Cardiorespiratory Fitness after Myocardial Infarction: A Pilot Study.

Authors:  Ryo Miyazawa; Yoshitaka Iso; Miki Tsujiuchi; Makoto Shoji; Tetsuya Takahashi; Shinji Koba; Mio Ebato; Tetsuo Miyagawa; Eiichi Geshi; Hiroshi Suzuki
Journal:  Prog Rehabil Med       Date:  2021-03-18

6.  lncRNA Ttc3-209 Promotes the Apoptosis of Retinal Ganglion Cells in Retinal Ischemia Reperfusion Injury by Targeting the miR-484/Wnt8a Axis.

Authors:  Ran Zhang; Yuqing Feng; Jinfang Lu; Yanni Ge; Huiling Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

Review 7.  Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology.

Authors:  Sarath Babu Nukala; Jordan Jousma; Yoonje Cho; Won Hee Lee; Sang-Ging Ong
Journal:  Cell Biosci       Date:  2022-03-04       Impact factor: 7.133

Review 8.  Noncoding RNAs in doxorubicin-induced cardiotoxicity and their potential as biomarkers and therapeutic targets.

Authors:  Hong-Ge Fa; Wen-Guang Chang; Xue-Juan Zhang; Dan-Dan Xiao; Jian-Xun Wang
Journal:  Acta Pharmacol Sin       Date:  2020-07-21       Impact factor: 6.150

9.  Huaier Suppresses Breast Cancer Progression via linc00339/miR-4656/CSNK2B Signaling Pathway.

Authors:  Wei Wang; Xiaolong Wang; Chen Li; Tong Chen; Ning Zhang; Yiran Liang; Yaming Li; Hanwen Zhang; Ying Liu; Xiaojin Song; Wenjing Zhao; Bing Chen; Lijuan Wang; Qifeng Yang
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

Review 10.  Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening.

Authors:  Paz Ovics; Danielle Regev; Polina Baskin; Mor Davidor; Yuval Shemer; Shunit Neeman; Yael Ben-Haim; Ofer Binah
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.